Targets regulated by increased activities of NF-κB transcription factors in PDA are survival genes such as survivin14 and Bcl-215, or genes regulating chemoresistance such as P-gp and XIAP14, 15. Here, NFKB1 is linked to Patent ductus arteriosus.